BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Thurston Arthritis Research Center - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/tarc
X-WR-CALDESC:Events for Thurston Arthritis Research Center
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221019T110000
DTEND;TZID=America/New_York:20221019T120000
DTSTAMP:20260622T120823
CREATED:20220923T174608Z
LAST-MODIFIED:20220923T174757Z
UID:10000690-1666177200-1666180800@www.med.unc.edu
SUMMARY:UNC CCCR Speakers Series: Dr. Virginia Kraus; "Treatment stratification of patients based on biomarker profile"
DESCRIPTION:“Treatment Stratification of Patients Based on Biomarker Profile” \nBrief Description: Stratified medicine involves the use of biomarkers to differentiate patient populations into subsets (i.e. endotypes) that provide more detailed information about the specific causes of conditions\, and predict how patients will respond to a given drug or combination of drugs. The ability to successfully identify different osteoarthritis (OA) endotypes will increase chances of regulatory approval of drugs for OA and ultimately\, transform the current empirical medical practice to efficient data-driven individualized therapeutic strategies with lower risk of medical error. This talk will summarize currently proposed OA endotypes and current prospects and implications. \nVirginia Kraus\, MD\, PhD\nProfessor of Medicine\, Duke University School of Medicine\nMary Bernheim Distinguished Professor of Medicine\nProfessor of Pathology \nRegister to attend via Zoom: https://zoom.us/meeting/register/tJIocOmupzIuGNQI5NN5-ofZ8xdPniPOk_8h \n 
URL:https://www.med.unc.edu/tarc/event/unc-cccr-speakers-series-dr-virginia-kraus-treatment-stratification-of-patients-based-on-biomarker-profile/
LOCATION:Join Remotely
CATEGORIES:TARC CCCR Speaker Series
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221021T083000
DTEND;TZID=America/New_York:20221021T093000
DTSTAMP:20260622T120823
CREATED:20221017T151239Z
LAST-MODIFIED:20221017T151258Z
UID:10000693-1666341000-1666344600@www.med.unc.edu
SUMMARY:Rheumatology\, Allergy & Immunology Grand Rounds: Dr. Mildred Kwan\, "Secondary Hypogammaglobulinemia Following BCTT”
DESCRIPTION:“Secondary Hypogammaglobulinemia Following BCTT” \nDr. Mildred Kwan\nAssistant Professor of Medicine\nDivision of Rheumatology\, Allergy and Immunology \nFriday\, October 21\, 2022\n8:30a-9:30a \nJoin Zoom Meeting https://zoom.us/j/93369235083?pwd=TU9GQ2dsMitLVk96VjZSV3N4OHpYdz09 \nMeeting ID: 933 6923 5083\nPasscode: 363826\nOne tap mobile\n+13126266799\,\,93369235083#\,\,\,\,*363826# US (Chicago)\n+16465588656\,\,93369235083#\,\,\,\,*363826# US (New York \nThis activity has been planned and implemented under the sole supervision of the Course Directors\, Millie Kwan\, MD\, and Alfredo Rivadeneira\, MD\, in association with the UNC Office of Continuing Professional Development (CPD).  The course director and CPD staff have no relevant financial relationships with ineligible companies as defined by the ACCM.
URL:https://www.med.unc.edu/tarc/event/rheumatology-allergy-immunology-grand-rounds-dr-mildred-kwan-secondary-hypogammaglobulinemia-following-bctt/
LOCATION:Join Remotely
CATEGORIES:Rheumatology, Allergy and Immunology Grand Rounds
END:VEVENT
END:VCALENDAR